OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Dermatology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	431
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis	283
Psoriasis Prevalence in Adults in the United States	224
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis	203
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	150
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis	112
Prevalence of Hidradenitis Suppurativa	108
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine	107
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	105
Systemic Immunomodulatory Treatments for Atopic Dermatitis	95
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis	93
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	88
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	83
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic	81
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	76
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy	75
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis	74
UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color	67
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch	67
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride	67
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines	65
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children	63
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders	63
Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19	61
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab	61

Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic	58
Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US	57
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis	54
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis	53
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare	52
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis	51
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures	50
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis	50
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection	50
Prevalence of Vitiligo Among Adults in the United States	48
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma	47
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis	46
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma	44
Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	43
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome	43
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US	42
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients	42
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	40
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis	39
Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood	39
Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States	39
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort	39
Hidradenitis Suppurativa in the Pediatric Population	38
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	38
Surgical Interventions for Patients With Vitiligo	37
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer	37
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary	37
Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma	36
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	36
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis	35
Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors	35
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris	34
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis	34
Association of Lipid-Lowering Drugs With Risk of Psoriasis	33
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage	33
Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome	33
Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System	33
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	32
Incidence and Prevalence of Granuloma Annulare in the United States	32
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States	32
Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting	31
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis	31
Association Between Melanoma Detected During Routine Skin Checks and Mortality	30
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	29
Machine Learning–Based Deep Phenotyping of Atopic Dermatitis	29
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis	29
Assessment of Changes in Diversity in Dermatology Clinical Trials Between 2010-2015 and 2015-2020	29
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis	28
Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus	28
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer	27

Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis	27
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance	27
The Multidimensional Burden of Atopic Dermatitis Among Adults	27
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients	27
Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study	26
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection	26
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis	26
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic	26
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)	26
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis	25
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population	25
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis	25
Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis	25
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US	25
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms	25
Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid	24
Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	24
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis	24
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma	24
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy	24
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa	24
The Genomic and Phenotypic Landscape of Ichthyosis	24
Association of Spironolactone Use With Risk of Cancer	23
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma	23
Long-term Outcomes and Prognosis in New-Onset Psoriasis	23
Mycosis Fungoides in Children and Adolescents	23
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma	23
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis	23
Postmarketing Cases of Enfortumab Vedotin–Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis	23
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)	23
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases	23
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities	22
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma	22
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid	22
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	22
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	22
Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata	22
Isotretinoin Laboratory Monitoring in Acne Treatment	21
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	21
Treatment of Kimura Disease With Dupilumab	21
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris	21
Dermatologists’ Perspectives on Artificial Intelligence and Augmented Intelligence — A Cross-sectional Survey	21
Evaluation of Pharmacologic Treatments for H₁ Antihistamine–Refractory Chronic Spontaneous Urticaria	21
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy	21
Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea	21
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus	21
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	20
Differences Between Children and Adults With Hidradenitis Suppurativa	20
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum	20
Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis	20
Evaluation of Stigma Toward Individuals With Alopecia	20
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis	20
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis	20
Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort	20
Allergic Contact Dermatitis	20
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity	20
Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection	19
Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma	19
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States	19
Association of Atopic Dermatitis Severity With Learning Disability in Children	19
Epidermolysis Bullosa Pruriginosa Treated With Baricitinib	19
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	19
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	18
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	18
Keloids	18
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	18
Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid	18
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017	18
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis	18
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	18
Treatment of Oral Erosive Lichen Planus With Upadacitinib	18
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis	18
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	18
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid	18
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency	18
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis	17
Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease	17
The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV	17
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)	17
Association Between Atopic Dermatitis and Educational Attainment in Denmark	17

Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits	17
A Mutational Survey of Acral Nevi	17
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	17
An Evaluation of the Performance of Current Morphea Subtype Classifications	17
Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo	17
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	17
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	17
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	16
Trends of Research Output of Allopathic Medical Students Matching Into Dermatology, 2007-2018	16
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe	16
Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss	16
Association of Sensorineural Hearing Loss in Patients With Alopecia Areata	16
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis	16
Shared Decision-making in Dermatology	15
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults	15
Inflation-Adjusted Trends in Medicare Reimbursement for Common Dermatologic Procedures, 2007-2021	15
Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children	15
Risks of Multiple Skin Cancers in Organ Transplant Recipients	15
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	15
FrontlineBRAFTesting–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies	15
Risk of Mortality After a Diagnosis of Melanoma In Situ	15
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years	15
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis	15
An Approach to Examining Tightly Coiled Hair Among Patients With Hair Loss in Race-Discordant Patient-Physician Interactions	14
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis	14
Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita	14
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis	14
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis	14
Validity of Using Billing Codes From Electronic Health Records to Estimate Skin Cancer Counts	14
Treatment of Grover Disease With Dupilumab	14
Patient Impressions and Outcomes After Clinic-Based Hidradenitis Suppurativa Surgery	14
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images	14
Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma	14
Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone	14
Treatment of Persistent Erythema Multiforme With Janus Kinase Inhibition and the Role of Interferon Gamma and Interleukin 15 in Its Pathogenesis	14
Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid	14
Evaluation of Dupilumab in Patients With Bullous Pemphigoid	14
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome	13
Real-time Analysis of Skin Biopsy Specimens With 2-Photon Fluorescence Microscopy	13
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema)	13
Differences in Merkel Cell Carcinoma Presentation and Outcomes Among Racial and Ethnic Groups	13
Early Detection and Prognostic Assessment of Cutaneous Melanoma	13
Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US	13
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	13
Mapping of Segmental and Partial Segmental Infantile Hemangiomas of the Face and Scalp	13
Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis	13
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	13
Legislative Efforts Restricting Care for Transgender People	13
Topical Corticosteroids and Glucocorticoid-Induced Osteoporosis—Cumulative Dose and Duration Matter	13
Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data	13
Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors	13
Evaluation of Etanercept for Treatment of Reactive Infectious Mucocutaneous Eruption	12
Treatment of Severe Nail Lichen Planus With Baricitinib	12
Risk of Bias and Error From Data Sets Used for Dermatologic Artificial Intelligence	12
Shared Decision-Making, Therapeutic Choice, and Decisional Regret in Patients With Alopecia Areata	12
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	12
Prurigo Nodularis	12
Pigmented Fungiform Papillae of the Tongue	12
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants	12
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis	12
Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea	12
Antibiotic Stewardship in Dermatology—Reducing the Risk of Prolonged Antimicrobial Resistance in Skin	12
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis	12
Treatment With Anifrolumab for Discoid Lupus Erythematosus	12
Treatment of Livedoid Vasculopathy With Baricitinib	12
Skin Cancer Risk Factors and Screening Among Asian American Individuals	12
Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level	12
Homozygous MEFV Gene Variant and Pyrin-Associated Autoinflammation With Neutrophilic Dermatosis	11
Improvement of Chronic Kidney Disease–Associated Pruritus After Treatment With Intravenous Naloxone	11
Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States	11
Assessment of the Diagnostic Accuracy of Baseline Clinical Examination and Ultrasonographic Imaging for the Detection of Lymph Node Metastasis in Patients With High-risk Cutaneous Squamous Cell Carcin	11
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	11
Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination	11
Vitiligo	11
Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma	11
Genetic Variants Associated With Hidradenitis Suppurativa	11
Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts	11
Expert Knowledge, Attitudes, and Practices in Management of Hidradenitis Suppurativa Pain	11
Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis	11
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders	11
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	11
Differences in Outpatient Dermatology Encounter Work Relative Value Units and Net Payments by Patient Race, Sex, and Age	11
Out-of-Pocket Costs of Specialty Medications for Psoriasis and Psoriatic Arthritis Treatment in the Medicare Population	11
Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users	11
How Dermatologists Can Address the Structural and Social Determinants of Health—From Awareness to Action	11
Resisting Racism in Dermatology	11
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients	11
Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma	10
Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra Pilaris	10
Circulating Brodalumab Levels and Therapy Outcomes in Patients With Psoriasis Treated With Brodalumab	10
Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma	10
Patient-Reported Outcomes in Dermatology	10
Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa	10
Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia	10
External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort	10